We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+26.39%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$133B
AUM Growth
+$15.7B
(+13%)
Cap. Flow
-$1.75B
Cap. Flow
% of AUM
-1.32%
Top 10 Holdings %
Top 10 Hldgs %
30.35%
Holding
4,370
New
224
Increased
1,883
Reduced
1,827
Closed
183
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$117M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$117M |
| 3 |
SPCX
SpaceX
SPCX
|
+$100M |
| 4 |
P
Everpure Inc
P
|
+$67.3M |
| 5 |
Roku
ROKU
|
+$53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$212M |
| 2 |
Microsoft
MSFT
|
+$156M |
| 3 |
Amazon
AMZN
|
+$142M |
| 4 |
Honeywell
HON
|
+$119M |
| 5 |
NVIDIA
NVDA
|
+$94.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.1% |
| 2 | Financials | 11.93% |
| 3 | Industrials | 10.35% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Healthcare | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Tigo Energy
TYGO
$66M
| $61.3K | ﹤0.01% |
+26,291
| New | +$99K |
|
3277
Sanara MedTech
SMTI
$322M
| $60.1K | ﹤0.01% |
2,550
+380
| +18% | +$7.86K |
|
|
CARL
3278
Carlsmed
CARL
$412M
| $60.1K | ﹤0.01% |
5,788
+607
| +12% | +$6.38K |
|
|
AMRN
3279
Amarin Corp
AMRN
$279M
| $59.5K | ﹤0.01% |
3,733
+394
| +12% | +$5.82K |
|
3280
Silvercrest Asset Management
SAMG
$80.6M
| $59.2K | ﹤0.01% |
5,860
-5,172
| -47% | -$63K |
|
3281
MaxCyte
MXCT
$121M
| $59K | ﹤0.01% |
47,973
-74,321
| -61% | -$74.1K |
|
3282
Riverview Bancorp
RVSB
$119M
| $57.9K | ﹤0.01% |
10,664
-14,448
| -58% | -$80K |
|
3283
SelectQuote
SLQT
$70.6M
| $57K | ﹤0.01% |
67,745
-94,166
| -58% | -$85.7K |
|
3284
Aldeyra Therapeutics
ALDX
$73M
| $56.8K | ﹤0.01% |
26,652
-42,553
| -61% | -$73.1K |
|
|
RZLV
3285
Rezolve AI
RZLV
$909M
| $56.8K | ﹤0.01% |
18,017
-199,154
| -92% | -$524K |
|
|
NBTX
3286
Nanobiotix
NBTX
$1.7B
| $56.6K | ﹤0.01% |
1,502
-779
| -34% | -$29K |
|
3287
Smith-Midland
SMID
$129M
| $56.3K | ﹤0.01% |
1,943
-1,857
| -49% | -$57.8K |
|
3288
Humacyte
HUMA
$155M
| $55.7K | ﹤0.01% |
71,441
-103,108
| -59% | -$95.5K |
|
3289
SB Financial Group
SBFG
$187M
| $55.3K | ﹤0.01% |
2,187
-4,233
| -66% | -$93.9K |
|
3290
Armata Pharmaceuticals
ARMP
$139M
| $54.8K | ﹤0.01% |
+8,453
| New | +$77.5K |
|
3291
HireQuest
HQI
$278M
| $54.1K | ﹤0.01% |
4,311
+451
| +12% | +$5.38K |
|
3292
Mammoth Energy Services
TUSK
$143M
| $54K | ﹤0.01% |
16,609
-16,254
| -49% | -$47.6K |
|
3293
Roadzen
RDZN
$119M
| $53.7K | ﹤0.01% |
+36,805
| New | +$58.4K |
|
3294
XPeng
XPEV
$9.69B
| $53K | ﹤0.01% |
4,004
+85
| +2% | +$1.35K |
|
|
ZENA
3295
ZenaTech Inc
ZENA
$126M
| $53K | ﹤0.01% |
+35,305
| New | +$63.3K |
|
|
CANF
3296
Can-Fite BioPharma American Depositary Shares
CANF
$4.63M
| $51.8K | ﹤0.01% |
17,433
-3,475
| -17% | -$10.9K |
|
3297
Forrester Research
FORR
$217M
| $51.6K | ﹤0.01% |
6,135
-8,424
| -58% | -$55K |
|
3298
First Guaranty Bancshares
FGBI
$132M
| $51.5K | ﹤0.01% |
+5,110
| New | +$49.2K |
|
3299
Intellicheck
IDN
$48.4M
| $51.4K | ﹤0.01% |
+12,532
| New | +$75.1K |
|
3300
Gildan
GIL
$7.59B
| $51.3K | ﹤0.01% |
995
+90
| +10% | +$5.17K |
|
Similar funds
RhumbLine Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, RhumbLine Advisers held 4,370 positions worth $133B, up 13% from $117B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
RhumbLine Advisers's Q2 2026 filing shows 224 new, 1,883 increased, 1,827 reduced and 183 closed positions. Its largest new stake was Honeywell Aerospace: 529,091 shares worth $117M. The largest sale was Apple, an estimated $212M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- RhumbLine Advisers's largest Q2 2026 buy was Honeywell Aerospace: 529,091 shares worth $117M.
- RhumbLine Advisers added most to Marvell Technology in Q2 2026, an estimated $117M increase.
- RhumbLine Advisers's biggest Q2 2026 reduction was Apple, cutting an estimated $212M.
- RhumbLine Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $53.5M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $133B portfolio in Q2 2026.
- RhumbLine Advisers opened 224 new positions and closed 183 in Q2 2026.
- RhumbLine Advisers's portfolio value rose 13% quarter-over-quarter to $133B.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.